IGM Biosciences Inc
NASDAQ:IGMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IGM Biosciences Inc
NASDAQ:IGMS
|
US |
|
Imperial Oil Ltd
TSX:IMO
|
CA |
|
Brii Biosciences Ltd
HKEX:2137
|
CN |
|
BKW AG
SIX:BKW
|
CH |
|
A
|
Alucon PCL
SET:ALUCON
|
TH |
|
Coeur Mining, Inc
TSX:CDE
|
US |
|
Gopal Iron and Steels Company (Gujarat) Ltd
BSE:531913
|
IN |
|
ADMA Biologics Inc
NASDAQ:ADMA
|
US |
|
Keyera Corp
TSX:KEY
|
CA |
|
F
|
Flowers Foods Inc
F:FWF
|
US |
|
R
|
Rio Tinto PLC
DUS:RIO1
|
UK |
|
C
|
CHCX Resources Inc
OTC:CHCX
|
US |
|
N
|
Northern Trust Corp
LSE:0K91
|
US |
|
H
|
Henry Schein Inc
XMUN:HS2
|
US |
|
V
|
Viet Phat Import Export Trading Investment JSC
VN:VPG
|
VN |
|
B
|
Burlington Stores Inc
F:BUI
|
US |
|
Dyaco International Inc
TWSE:1598
|
TW |
|
Permian Resources Corp
NYSE:PR
|
US |
|
B
|
Black Diamond Group Ltd
OTC:BDIMF
|
CA |
Bankruptcy Probability
IGM Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IGM Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
IGM Biosciences Inc
NASDAQ:IGMS
|
76.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
459.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
87.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IGM Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IGM Biosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
